MS Risk Factors and Outcomes

Volume 5, Issue 2

MS Risk Factors and Outcomes

In this issue:

In her Expert Commentary, Dr. Melanie Ward from West Virginia University’s Rockefeller Neuroscience Institute provided analysis of the newer data describing the modifiable and nonmodifiable risk factors for developing MS and/or increasing the rate of disease progression and disability.

Join us for this podcast as Dr. Ward explains how these findings can affect clinical practice to improve overall care of individuals with MS.

Learning objectives:

Identify key MS risk factors and discuss how they might influence each other.
Describe how counseling about modifiable risk factors can improve patient outcomes.

Author:

Melanie Ward, MD

Assistant Professor
West Virginia University Rockefeller Neuroscience Institute
Morgantown, WV

Guest Faculty Disclosures

Dr. Ward has indicated that she has received consulting fees from Novartis AG, Genentech, Inc., Bristol-Myers Squibb, and grant or research support from Genentech, Inc. 

Unlabeled/Unapproved Uses

Dr. Ward has indicated that there will be no references to the unlabeled/unapproved uses of any drugs or products.

Program Directors:

Pavan Bhargava, MBBS, MD

Assistant Professor
Department of Neurology
Johns Hopkins School of Medicine
Baltimore, MD

Lisa Fox, PA-C, MPAS

Department of Neurology
Johns Hopkins Hospital
Baltimore, MD

Michael Kornberg, MD, PhD

Assistant Professor
Department of Neurology
Johns Hopkins School of Medicine
Baltimore, MD

Guest Faculty Disclosures:

Dr. Ward has indicated that she has received consulting fees from Novartis AG, Genentech, Inc., Bristol-Myers Squibb, and grant or research support from Genentech, Inc. 

Unlabeled/Unapproved Uses:

Dr. Ward has indicated that there will be no references to the unlabeled/unapproved uses of any drugs or products.

Length of activity:

0.5 hour Physicians
0.5 contact hour Nurses

Launch date: March 8, 2023
Expiration date: March 7, 2025

Start Issue